Cargando…
Functional impairment in patients with major depressive disorder: the 2-year PERFORM study
BACKGROUND: The Prospective Epidemiological Research on Functioning Outcomes Related to Major depressive disorder (PERFORM) study describes the course of depressive symptoms, perceived cognitive symptoms, and functional impairment over 2 years in outpatients with major depressive disorder (MDD) and...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767094/ https://www.ncbi.nlm.nih.gov/pubmed/29386897 http://dx.doi.org/10.2147/NDT.S146098 |
_version_ | 1783292478982455296 |
---|---|
author | Hammer-Helmich, Lene Haro, Josep Maria Jönsson, Bengt Tanguy Melac, Audrey Di Nicola, Sylvie Chollet, Julien Milea, Dominique Rive, Benoît Saragoussi, Delphine |
author_facet | Hammer-Helmich, Lene Haro, Josep Maria Jönsson, Bengt Tanguy Melac, Audrey Di Nicola, Sylvie Chollet, Julien Milea, Dominique Rive, Benoît Saragoussi, Delphine |
author_sort | Hammer-Helmich, Lene |
collection | PubMed |
description | BACKGROUND: The Prospective Epidemiological Research on Functioning Outcomes Related to Major depressive disorder (PERFORM) study describes the course of depressive symptoms, perceived cognitive symptoms, and functional impairment over 2 years in outpatients with major depressive disorder (MDD) and investigates the patient-related factors associated with functional impairment. METHODS: This was a 2-year observational study in 1,159 outpatients with MDD aged 18–65 years who were either initiating antidepressant monotherapy or undergoing their first switch of antidepressant. Functional impairment was assessed by the Sheehan Disability Scale and the Work Productivity and Activity Impairment questionnaire. Patients assessed depression severity using the nine-item Patient Health Questionnaire and severity of perceived cognitive symptoms using the five-item Perceived Deficit Questionnaire. To investigate which patient-related factors were associated with functional impairment, univariate analyses of variance were performed to identify relevant factors that were then included in multivariate analyses of covariance at baseline, month 2, months 6 and 12 combined, and months 18 and 24 combined. RESULTS: The greatest improvement in depressive symptoms, perceived cognitive symptoms, and functional impairment was seen immediately (within 2 months) following initiation or switch of antidepressant therapy, followed by more gradual improvement and long-term stabilization. Improvement in perceived cognitive symptoms was less marked than improvement in depressive symptoms during the acute treatment phase. Functional impairment in patients with MDD was not only associated with severity of depressive symptoms but also independently associated with severity of perceived cognitive symptoms when adjusted for depression severity throughout the 2 years of follow-up. CONCLUSION: These findings highlight the burden of functional impairment in MDD and the importance of recognizing and managing cognitive symptoms in daily practice. |
format | Online Article Text |
id | pubmed-5767094 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-57670942018-01-31 Functional impairment in patients with major depressive disorder: the 2-year PERFORM study Hammer-Helmich, Lene Haro, Josep Maria Jönsson, Bengt Tanguy Melac, Audrey Di Nicola, Sylvie Chollet, Julien Milea, Dominique Rive, Benoît Saragoussi, Delphine Neuropsychiatr Dis Treat Original Research BACKGROUND: The Prospective Epidemiological Research on Functioning Outcomes Related to Major depressive disorder (PERFORM) study describes the course of depressive symptoms, perceived cognitive symptoms, and functional impairment over 2 years in outpatients with major depressive disorder (MDD) and investigates the patient-related factors associated with functional impairment. METHODS: This was a 2-year observational study in 1,159 outpatients with MDD aged 18–65 years who were either initiating antidepressant monotherapy or undergoing their first switch of antidepressant. Functional impairment was assessed by the Sheehan Disability Scale and the Work Productivity and Activity Impairment questionnaire. Patients assessed depression severity using the nine-item Patient Health Questionnaire and severity of perceived cognitive symptoms using the five-item Perceived Deficit Questionnaire. To investigate which patient-related factors were associated with functional impairment, univariate analyses of variance were performed to identify relevant factors that were then included in multivariate analyses of covariance at baseline, month 2, months 6 and 12 combined, and months 18 and 24 combined. RESULTS: The greatest improvement in depressive symptoms, perceived cognitive symptoms, and functional impairment was seen immediately (within 2 months) following initiation or switch of antidepressant therapy, followed by more gradual improvement and long-term stabilization. Improvement in perceived cognitive symptoms was less marked than improvement in depressive symptoms during the acute treatment phase. Functional impairment in patients with MDD was not only associated with severity of depressive symptoms but also independently associated with severity of perceived cognitive symptoms when adjusted for depression severity throughout the 2 years of follow-up. CONCLUSION: These findings highlight the burden of functional impairment in MDD and the importance of recognizing and managing cognitive symptoms in daily practice. Dove Medical Press 2018-01-09 /pmc/articles/PMC5767094/ /pubmed/29386897 http://dx.doi.org/10.2147/NDT.S146098 Text en © 2018 Hammer-Helmich et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Hammer-Helmich, Lene Haro, Josep Maria Jönsson, Bengt Tanguy Melac, Audrey Di Nicola, Sylvie Chollet, Julien Milea, Dominique Rive, Benoît Saragoussi, Delphine Functional impairment in patients with major depressive disorder: the 2-year PERFORM study |
title | Functional impairment in patients with major depressive disorder: the 2-year PERFORM study |
title_full | Functional impairment in patients with major depressive disorder: the 2-year PERFORM study |
title_fullStr | Functional impairment in patients with major depressive disorder: the 2-year PERFORM study |
title_full_unstemmed | Functional impairment in patients with major depressive disorder: the 2-year PERFORM study |
title_short | Functional impairment in patients with major depressive disorder: the 2-year PERFORM study |
title_sort | functional impairment in patients with major depressive disorder: the 2-year perform study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767094/ https://www.ncbi.nlm.nih.gov/pubmed/29386897 http://dx.doi.org/10.2147/NDT.S146098 |
work_keys_str_mv | AT hammerhelmichlene functionalimpairmentinpatientswithmajordepressivedisorderthe2yearperformstudy AT harojosepmaria functionalimpairmentinpatientswithmajordepressivedisorderthe2yearperformstudy AT jonssonbengt functionalimpairmentinpatientswithmajordepressivedisorderthe2yearperformstudy AT tanguymelacaudrey functionalimpairmentinpatientswithmajordepressivedisorderthe2yearperformstudy AT dinicolasylvie functionalimpairmentinpatientswithmajordepressivedisorderthe2yearperformstudy AT cholletjulien functionalimpairmentinpatientswithmajordepressivedisorderthe2yearperformstudy AT mileadominique functionalimpairmentinpatientswithmajordepressivedisorderthe2yearperformstudy AT rivebenoit functionalimpairmentinpatientswithmajordepressivedisorderthe2yearperformstudy AT saragoussidelphine functionalimpairmentinpatientswithmajordepressivedisorderthe2yearperformstudy |